title: Adjuvant treatment with tamoxifen. Recruitment into studies assessing optimum duration of treatment must continue.
authors.forename: H
authors.initials: H
authors.lastname: Earl
authors.forename: P
authors.initials: P
authors.lastname: Baker
authors.forename: D
authors.initials: D
authors.lastname: Kerr
authors.forename: M
authors.initials: M
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Gray
authors.forename: M
authors.initials: M
authors.lastname: Baum
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen